Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Hull (Sheffield, United Kingdom), S. Foster (Sheffield, United Kingdom), M. Brockhurst (Manchester, United Kingdom), A. Condliffe (Sheffield, United Kingdom). Evolution of tetracycline resistant S. aureus in hypoxia. 677

Member's Comments

No comment yet.

Related content which might interest you: Treatment challenges in methicillin resistant Staphylococcus aureus infections Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Mechanisms of acquisition of resistance in Staphylococcus aureus Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Cell wall deficiency: a novel mechanism for methicillin resistance in Staphylococcus aureus Source: Eur Respir J 2005; 26: Suppl. 49, 94s Year: 2005 Exposure to sub-lethal levels of penicillin G and high osmotic potential leads to stable antibiotic resistance in Staphylococcus aureus Source: Eur Respir J 2002; 20: Suppl. 38, 421s Year: 2002 Emergence of penicillin resistant Streptococcus pneumoniae in Pakistan Source: Eur Respir J 2005; 26: Suppl. 49, 639s Year: 2005 CusS-cusR mediate carbapenem-resistant Klebsiella pneumoniae resistant to tigecycline. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Staphlococcus aureus: susceptibility to antibacterial drugs and rate of MRSA Source: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006 Staphylococcus aureus sensitivity changes to antibiotics under the influence of dissolved ozone Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Changes in susceptibility to antibiotics staphylococcus aureus under effect of dissolved ozone Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 Human airway epithelial cell response to Pseudomonas aeruginosa virulence factors preceded or not by Staphylococcus aureus Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006 The efficacies of macrolides in a murine model of methicillin-resistant staphylococcus aureus hematogenous pulmonary infection Source: Eur Respir J 2002; 20: Suppl. 38, 357s Year: 2002 Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae Source: Eur Respir J 2006; 27: 1020-1025 Year: 2006 Resistance of Streptococcus pneumoniae to penicillin, azitromycin, ciprofloxacyn and ceftriaxon Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001 Resistance to penicillin among the Streptococcus pneumoniae in Turkey Source: Eur Respir J 2001; 18: 436 Year: 2001 Predictive factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a MRSA screening protocol. Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Peculiarities of community-acquired pneumonia course, caused by multiresistant strains of S. pneumoniae Source: Eur Respir J 2006; 28: Suppl. 50, 165s Year: 2006 Synergistic activity of colistin in combination with N-acetylcysteine against colistin-resistant Acinetobacter Baumannii grown in biofilms Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 What is MRSA? Source: Eur Respir J 2009; 34: 1190-1196 Year: 2009 Clinical implications of agr operon activity in staphylococcus aureus strains isolated from respiratory samples Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues Year: 2015